Magnesium in PDB 2vf6: Human Fdps Synthase in Complex with Minodronate
Enzymatic activity of Human Fdps Synthase in Complex with Minodronate
All present enzymatic activity of Human Fdps Synthase in Complex with Minodronate:
2.5.1.1;
Protein crystallography data
The structure of Human Fdps Synthase in Complex with Minodronate, PDB code: 2vf6
was solved by
A.G.Evdokimov,
B.L.Barnett,
F.H.Ebetino,
M.Pokross,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
78.57 /
2.10
|
Space group
|
P 41 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
111.207,
111.207,
69.059,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.9 /
25.9
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Human Fdps Synthase in Complex with Minodronate
(pdb code 2vf6). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 3 binding sites of Magnesium where determined in the
Human Fdps Synthase in Complex with Minodronate, PDB code: 2vf6:
Jump to Magnesium binding site number:
1;
2;
3;
Magnesium binding site 1 out
of 3 in 2vf6
Go back to
Magnesium Binding Sites List in 2vf6
Magnesium binding site 1 out
of 3 in the Human Fdps Synthase in Complex with Minodronate
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Human Fdps Synthase in Complex with Minodronate within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg1352
b:36.2
occ:1.00
|
O4
|
A:M0N1351
|
1.9
|
30.9
|
1.0
|
O
|
A:HOH2119
|
2.1
|
30.9
|
1.0
|
O
|
A:HOH2122
|
2.1
|
37.7
|
1.0
|
O1
|
A:M0N1351
|
2.1
|
32.2
|
1.0
|
OD2
|
A:ASP243
|
2.2
|
34.2
|
1.0
|
O
|
A:HOH2117
|
2.3
|
34.5
|
1.0
|
P2
|
A:M0N1351
|
3.2
|
32.3
|
1.0
|
CG
|
A:ASP243
|
3.2
|
32.6
|
1.0
|
P1
|
A:M0N1351
|
3.3
|
33.4
|
1.0
|
C9
|
A:M0N1351
|
3.5
|
34.1
|
1.0
|
O
|
A:M0N1351
|
3.5
|
31.8
|
1.0
|
OD1
|
A:ASP243
|
3.6
|
36.8
|
1.0
|
NZ
|
A:LYS257
|
3.8
|
50.9
|
1.0
|
O
|
A:HOH2171
|
3.9
|
30.4
|
1.0
|
O5
|
A:M0N1351
|
4.0
|
26.6
|
1.0
|
O
|
A:HOH2129
|
4.0
|
50.7
|
1.0
|
O
|
A:ASP243
|
4.1
|
36.5
|
1.0
|
OD1
|
A:ASP247
|
4.1
|
36.4
|
1.0
|
O2
|
A:M0N1351
|
4.2
|
37.9
|
1.0
|
OD2
|
A:ASP261
|
4.3
|
33.1
|
1.0
|
OD1
|
A:ASP261
|
4.3
|
33.2
|
1.0
|
O
|
A:HOH2049
|
4.3
|
29.6
|
1.0
|
NE2
|
A:GLN240
|
4.3
|
32.9
|
1.0
|
OD1
|
A:ASP244
|
4.4
|
31.4
|
1.0
|
O6
|
A:M0N1351
|
4.4
|
27.1
|
1.0
|
O3
|
A:M0N1351
|
4.4
|
28.9
|
1.0
|
C
|
A:ASP243
|
4.5
|
36.0
|
1.0
|
CB
|
A:ASP243
|
4.5
|
36.0
|
1.0
|
CB
|
A:ASP247
|
4.6
|
41.0
|
1.0
|
CG
|
A:ASP247
|
4.6
|
41.7
|
1.0
|
CG
|
A:ASP261
|
4.7
|
35.8
|
1.0
|
O
|
A:HOH2168
|
4.7
|
29.4
|
1.0
|
MG
|
A:MG1353
|
4.8
|
27.6
|
1.0
|
N
|
A:ASP244
|
5.0
|
30.9
|
1.0
|
|
Magnesium binding site 2 out
of 3 in 2vf6
Go back to
Magnesium Binding Sites List in 2vf6
Magnesium binding site 2 out
of 3 in the Human Fdps Synthase in Complex with Minodronate
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Human Fdps Synthase in Complex with Minodronate within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg1353
b:27.6
occ:1.00
|
O
|
A:HOH2049
|
2.0
|
29.6
|
1.0
|
O
|
A:HOH2044
|
2.0
|
28.5
|
1.0
|
O2
|
A:M0N1351
|
2.0
|
37.9
|
1.0
|
O5
|
A:M0N1351
|
2.0
|
26.6
|
1.0
|
OD2
|
A:ASP103
|
2.2
|
30.0
|
1.0
|
OD2
|
A:ASP107
|
2.2
|
34.6
|
1.0
|
CG
|
A:ASP103
|
3.1
|
35.0
|
1.0
|
MG
|
A:MG1354
|
3.2
|
33.5
|
1.0
|
P1
|
A:M0N1351
|
3.2
|
33.4
|
1.0
|
CG
|
A:ASP107
|
3.3
|
39.6
|
1.0
|
P2
|
A:M0N1351
|
3.3
|
32.3
|
1.0
|
OD1
|
A:ASP103
|
3.4
|
30.7
|
1.0
|
C9
|
A:M0N1351
|
3.7
|
34.1
|
1.0
|
CB
|
A:ASP107
|
3.7
|
26.5
|
1.0
|
O1
|
A:M0N1351
|
3.8
|
32.2
|
1.0
|
O
|
A:HOH2168
|
3.9
|
29.4
|
1.0
|
O4
|
A:M0N1351
|
4.0
|
30.9
|
1.0
|
C8
|
A:M0N1351
|
4.0
|
29.2
|
1.0
|
NH2
|
A:ARG112
|
4.1
|
30.9
|
1.0
|
O
|
A:HOH2170
|
4.1
|
28.2
|
1.0
|
O6
|
A:M0N1351
|
4.4
|
27.1
|
1.0
|
OD1
|
A:ASP107
|
4.4
|
30.2
|
1.0
|
O
|
A:HOH2122
|
4.4
|
37.7
|
1.0
|
O
|
A:HOH2135
|
4.4
|
32.0
|
1.0
|
O
|
A:ASP103
|
4.4
|
26.0
|
1.0
|
OG
|
A:SER109
|
4.4
|
31.5
|
1.0
|
O3
|
A:M0N1351
|
4.5
|
28.9
|
1.0
|
CB
|
A:ASP103
|
4.5
|
26.9
|
1.0
|
OD1
|
A:ASP104
|
4.6
|
27.5
|
1.0
|
O
|
A:HOH2169
|
4.7
|
32.3
|
1.0
|
C
|
A:ASP103
|
4.7
|
29.9
|
1.0
|
MG
|
A:MG1352
|
4.8
|
36.2
|
1.0
|
O
|
A:HOH2136
|
4.8
|
31.9
|
1.0
|
O
|
A:HOH2171
|
4.9
|
30.4
|
1.0
|
O
|
A:HOH2050
|
4.9
|
25.9
|
1.0
|
|
Magnesium binding site 3 out
of 3 in 2vf6
Go back to
Magnesium Binding Sites List in 2vf6
Magnesium binding site 3 out
of 3 in the Human Fdps Synthase in Complex with Minodronate
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Human Fdps Synthase in Complex with Minodronate within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg1354
b:33.5
occ:1.00
|
O
|
A:HOH2170
|
2.0
|
28.2
|
1.0
|
O
|
A:HOH2050
|
2.0
|
25.9
|
1.0
|
OD1
|
A:ASP103
|
2.1
|
30.7
|
1.0
|
O
|
A:HOH2169
|
2.1
|
32.3
|
1.0
|
OD2
|
A:ASP107
|
2.1
|
34.6
|
1.0
|
O2
|
A:M0N1351
|
2.2
|
37.9
|
1.0
|
CG
|
A:ASP107
|
3.0
|
39.6
|
1.0
|
CG
|
A:ASP103
|
3.1
|
35.0
|
1.0
|
OD1
|
A:ASP107
|
3.1
|
30.2
|
1.0
|
MG
|
A:MG1353
|
3.2
|
27.6
|
1.0
|
P1
|
A:M0N1351
|
3.4
|
33.4
|
1.0
|
OD2
|
A:ASP103
|
3.4
|
30.0
|
1.0
|
O3
|
A:M0N1351
|
3.5
|
28.9
|
1.0
|
OD1
|
A:ASP174
|
3.7
|
38.0
|
1.0
|
NE2
|
A:GLN171
|
3.9
|
30.6
|
1.0
|
NZ
|
A:LYS266
|
4.1
|
44.9
|
1.0
|
CG
|
A:ASP174
|
4.2
|
39.3
|
1.0
|
OE1
|
A:GLN171
|
4.3
|
32.5
|
1.0
|
OD2
|
A:ASP174
|
4.3
|
33.5
|
1.0
|
O1
|
A:M0N1351
|
4.3
|
32.2
|
1.0
|
O
|
A:HOH2049
|
4.3
|
29.6
|
1.0
|
O
|
A:HOH2171
|
4.4
|
30.4
|
1.0
|
CB
|
A:ASP107
|
4.4
|
26.5
|
1.0
|
CB
|
A:ASP103
|
4.4
|
26.9
|
1.0
|
CD
|
A:GLN171
|
4.5
|
35.0
|
1.0
|
NZ
|
A:LYS200
|
4.6
|
30.9
|
1.0
|
C8
|
A:M0N1351
|
4.6
|
29.2
|
1.0
|
C9
|
A:M0N1351
|
4.7
|
34.1
|
1.0
|
C2
|
A:M0N1351
|
4.8
|
30.4
|
1.0
|
O5
|
A:M0N1351
|
4.8
|
26.6
|
1.0
|
O
|
A:HOH2044
|
4.8
|
28.5
|
1.0
|
O
|
A:ASP103
|
4.8
|
26.0
|
1.0
|
C3
|
A:M0N1351
|
5.0
|
23.8
|
1.0
|
N2
|
A:M0N1351
|
5.0
|
28.1
|
1.0
|
|
Reference:
A.G.Evdokimov,
B.L.Barnett,
F.H.Ebetino,
M.Pokross.
Human Fdps Synthase in Complex with Novel Inhibitor To Be Published.
Page generated: Wed Aug 14 05:11:21 2024
|